StockData
Shattuck Labs, Inc. logo

Shattuck Labs, Inc. (STTK) stock

STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$4.59−0.07 (-1.50%)

Close on Nov 17, 2026Market cap $460.67MP/E –Yield –

Shattuck Labs revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Shattuck Labs's revenue for the twelve months ending Jun 30, 2026 was $1.00M, down 66.6% year over year. For fiscal 2025 it was $1.00M, down 82.5% from the year before. The highest annual figure on record is $30.02M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.00M-82.5%
FY2024Dec 31, 2024$5.72M+245.3%
FY2023Dec 31, 2023$1.66M+154.1%
FY2022Dec 31, 2022$652.00K-97.8%
FY2021Dec 31, 2021$30.02M+202.2%
FY2020Dec 31, 2020$9.93M+0.5%
FY2019Dec 31, 2019$9.89M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$1.00M-66.6%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$3.00M+336.9%
Q2 FY2024Jun 30, 2024$1.61M+704.5%
Q1 FY2024Mar 31, 2024$1.12M+1856.1%
Q4 FY2023Dec 31, 2023$714.00K+83.1%
Q3 FY2023Sep 30, 2023$686.00K+223.6%
Q2 FY2023Jun 30, 2023$200.00K+300.0%
Q1 FY2023Mar 31, 2023$57.00K–
Q4 FY2022Dec 31, 2022$390.00K-98.7%
Q3 FY2022Sep 30, 2022$212.00K-88.8%
Q2 FY2022Jun 30, 2022$50.00K–
Q1 FY2022Mar 31, 2022$0-100.0%
Q4 FY2021Dec 31, 2021$30.08M+2141.3%
Q3 FY2021Sep 30, 2021$1.90M-22.0%
Q2 FY2021Jun 30, 2021-$4.23M-233.0%
Q1 FY2021Mar 31, 2021$2.27M-23.7%
Q4 FY2020Dec 31, 2020$1.34M-52.4%
Q3 FY2020Sep 30, 2020$2.44M+36.5%
Q2 FY2020Jun 30, 2020$3.18M–
Q1 FY2020Mar 31, 2020$2.98M–
Q4 FY2019Dec 31, 2019$2.82M–
Q3 FY2019Sep 30, 2019$1.78M–

More Shattuck Labs figures

See a number that looks wrong?